Abcam posts 33% profit growth but misses targets
0 mins. to read
ABCAM watched its shares sink by 12.80% to 1294p as it missed forecasts despite pre-tax profits climbing 33% to £69.1 million.
Latest
GAN shares boosted as client launches in US
0 mins. to read
AIM-listed gambling software and services outfit GAN has announced that its first US client has begun offering sports betting using its software.
RPC soars after takeover talks confirmed
0 mins. to read
Shares in FTSE 250 plastics manufacturer RPC Group shot up by 17.53% to 803.42p after it confirmed that it was in talks with two private equity firms.
2 FTSE 100 shares with turnaround potential
2 mins. to read
Robert Stephens discusses the recovery prospects of two underperforming FTSE 100 shares.
Bushveld Minerals dented by strike action
0 mins. to read
Vanadium miner Bushveld Minerals has announced that production has been halted at one of its primary assets due to unprotected industrial action.
ImmuPharma sinks as it announces Lupus drug plan
1 mins. to read
Shares in ImmuPharma fell by 5.55% to 19.15p after it announced that its lupus drug would be made available via a Managed Access Programme.
Greene King shares up as year after a strong summer
0 mins. to read
Greene King said like-for-like sales at its pubs in the first 18 weeks of the year were up by 2.8%, beating the wider market which grew by 1.2%.
Who falls first – Mr Trump or Madam Market?
14 mins. to read
The tide has turned for Mr Trump’s political fortunes. Thus far his credibility has been inextricably linked with the fortunes of the stock market. Victor Hill asks: Which will fall first – Mr Trump or the US equity market?
Evil Knievil: I call that terminal
0 mins. to read
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Avation shares rises as revenues climb
1 mins. to read
Master Investor exhibitor Avation has reported a 16% increase in revenues for the year ended 30th June as it added 5 new aircraft to its fleet.